Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

290
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

182
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Nanoparticle or conventional adjuvants: which one improves immune response against Brucellosis?

Pages

  360-366

Abstract

 Objective(s): Brucellosis is a common infectious disease among animals and humans. While subunit vaccines could be used as an efficient strategy against pathogens, they usually seem to be less immunogenic than live or killed vaccines. However, the use of a suitable adjuvant accompanied by subunit vaccines can be a good alternative to enhance the immune response. Materials and Methods: To find a proper adjuvant against Brucellosis, the immune response of induced mice by Aluminum hydroxide (AH), Incomplete Freund (IFA), and Chitosan Nanoparticle (CS) adjuvants in individuals and in combination with CS were assessed. Results: Immunization with CS stimulated higher interferon gamma (IFN-γ ) immunity, while there were no significant differences between rOMP25 (IFA), rOMP25 (AH), rOMP25 (AH-CS) and rOMP25 (IFA-CS) recombinant proteins. Tumor necrosis factor alpha (TNF-α ) analysis revealed there were no significant differencesbetween immunized groups and the positive control group, except for the treatment formulated in single IFA. Furthermore, unlike IFN-γ , there was a reverse interleukin-4 (IL-4) immune response trend for treatments, as rOMP25 (CS) displayed the lowest response. rOMP25 (CS) induced higher titer of total antibody than the other ones. Although the recombinant proteins emulsified in different adjuvants induced similar titer of IgG1 antibody, the ones that were formulated in CS, IFA and IFA-CS showed a higher titer of IgG2a. The cell proliferation assay demonstrating the antigen-specific cell proliferative response could be promoted after immunization with CS. Conclusion: CS whether single or in combination with IF adjuvants has potential to improve Th1-Th2 responses.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    YOUSEFI, SOHEIL, ABBASSI DALOII, TOOBA, TAHMOORESPUR, MOJTABA, & SEKHAVATI, MOHAMMAD HADI. (2019). Nanoparticle or conventional adjuvants: which one improves immune response against Brucellosis?. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 22(4), 360-366. SID. https://sid.ir/paper/721799/en

    Vancouver: Copy

    YOUSEFI SOHEIL, ABBASSI DALOII TOOBA, TAHMOORESPUR MOJTABA, SEKHAVATI MOHAMMAD HADI. Nanoparticle or conventional adjuvants: which one improves immune response against Brucellosis?. IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES[Internet]. 2019;22(4):360-366. Available from: https://sid.ir/paper/721799/en

    IEEE: Copy

    SOHEIL YOUSEFI, TOOBA ABBASSI DALOII, MOJTABA TAHMOORESPUR, and MOHAMMAD HADI SEKHAVATI, “Nanoparticle or conventional adjuvants: which one improves immune response against Brucellosis?,” IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, vol. 22, no. 4, pp. 360–366, 2019, [Online]. Available: https://sid.ir/paper/721799/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top